Stress‐Induced Degradation Profiling of Evogliptin by Stability‐Indicating Reversed‐Phase High‐Performance Liquid Chromatography and Liquid Chromatography–Mass Spectrometry
Biomedical Chromatography · 2026-12 · 40 (12)
DOI: 10.1002/bmc.70654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 05.11.2026. Verfasst von Bhairavi Saraf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of School of Basic and Applied Sciences, Sangam University, Bhilwara, Rajasthan, India. Hauptthemen laut MEDLINE: Chromatography, Reverse-Phase, Liquid Chromatography-Mass Spectrometry, Piperidines, Piperazines. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
A stability‐indicating reversed‐phase high‐performance liquid chromatographic method was developed and validated for quantitative determination of evogliptin in bulk drug substance and a marketed tablet formulation, followed by supporting liquid chromatography‐mass spectrometry investigation of selected stress‐associated components. Separation was achieved on an Eclipse XDB C8 column (250 × 4.6 mm, 5 μm) using acetonitrile and 0.1% formic acid in water (80:20, v/v) at 1.0 mL/min, with photodiode‐array detection at 268 nm and a 10 min run time. The method was linear over 10–60 μg/mL ( R 2 = 0.9993), with repeatability and intermediate precision below 2%. Mean recoveries ranged from 99.657 to 100.555%. The marketed tablet assay was 100.161 ± 0.333%. Forced‐degradation studies showed parent‐drug response losses of 10.90%, 23.61%, and 9.08% under acidic hydrolysis, alkaline hydrolysis, and oxidative stress conditions, respectively. Thermal and photolytic solid‐state exposure produced only 0.40% and 0.08% response loss, respectively, under the conditions investigated. Full‐scan LC–MS showed ions at m/z 186.2, 363.3, and 417.4 associated with DP1, DP2, and DP3, respectively. These findings support stress association but not definitive structures, as product‐ion MS/MS, accurate‐mass measurements, and authentic degradation‐product standards were not used. This study integrates quantitative stability‐indicating chromatographic assessment with conservative mass‐spectrometric investigation of selected stress‐associated components.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of School of Basic and Applied Sciences, Sangam University, Bhilwara, Rajasthan, India.
- Department of Pharmacovigilance, Alkem Laboratories Pvt. Ltd., Mumbai, Maharashtra, India.
ORCID-Profile: Bhairavi Saraf, Preeti Mehta, Rahul Somani
Zitieren
APA
Saraf, B., Mehta, P., & Somani, R. (2026). Stress‐Induced Degradation Profiling of Evogliptin by Stability‐Indicating Reversed‐Phase High‐Performance Liquid Chromatography and Liquid Chromatography–Mass Spectrometry. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70654
Vancouver
Saraf B, Mehta P, Somani R. Stress‐Induced Degradation Profiling of Evogliptin by Stability‐Indicating Reversed‐Phase High‐Performance Liquid Chromatography and Liquid Chromatography–Mass Spectrometry. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70654
BibTeX
@article{Saraf2026,
author = {Saraf, Bhairavi and Mehta, Preeti and Somani, Rahul},
title = {Stress‐Induced Degradation Profiling of Evogliptin by Stability‐Indicating Reversed‐Phase High‐Performance Liquid Chromatography and Liquid Chromatography–Mass Spectrometry},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/bmc.70654}
}
EUVIMED